IRON
Disc Medicine Inc

383
Mkt Cap
$2.54B
Volume
345,127.00
52W High
$99.50
52W Low
$30.82
PE Ratio
-12.43
IRON Fundamentals
Price
$66.62
Prev Close
$67.91
Open
$67.49
50D MA
$75.69
Beta
1.09
Avg. Volume
526,677.30
EPS (Annual)
-$6.01
P/B
4.07
Rev/Employee
$0.00
$2,042.70
Loading...
Loading...
News
all
press releases
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection
Key PointsJean Franchi sold 11,156 shares of common stock in open-market transactions for a total value of ~$720,000, with an average price around $64.51 per share on Feb. 17 and Feb. 18, 2026...
Nasdaq News: Markets·13h ago
News Placeholder
More News
News Placeholder
Disc Medicine (NASDAQ:IRON) CFO Sells $24,378.18 in Stock
Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) CFO Jean Franchi sold 353 shares of the business's stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an...
MarketBeat·2d ago
News Placeholder
Disc Medicine (NASDAQ:IRON) Price Target Lowered to $83.00 at Truist Financial
Truist Financial reduced their price objective on Disc Medicine from $114.00 to $83.00 and set a "buy" rating on the stock in a research note on Friday...
MarketBeat·3d ago
News Placeholder
JPMorgan Chase & Co. Sells 90,737 Shares of Disc Medicine, Inc. $IRON
JPMorgan Chase & Co. decreased its stake in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 10.8% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The...
MarketBeat·3d ago
News Placeholder
Disc Medicine (NASDAQ:IRON) Releases Quarterly Earnings Results
Disc Medicine (NASDAQ:IRON - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($1.62) earnings per share for the quarter, topping analysts' consensus estimates...
MarketBeat·3d ago
News Placeholder
Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction
Key PointsHedge fund BVF added 650,000 shares of Disc Medicine in the fourth quarter...
Nasdaq News: Markets·4d ago
News Placeholder
Disc Medicine to Seek Traditional FDA Approval for Bitopertin After EPP CRL; APOLLO Data Due Q4
Disc Medicine (NASDAQ:IRON) executives said the company plans to pursue a traditional FDA approval for bitopertin in erythropoietic protoporphyria (EPP) after receiving a Complete Response Letter...
MarketBeat·6d ago
News Placeholder
Insider Selling: Disc Medicine (NASDAQ:IRON) CFO Sells 7,081 Shares of Stock
Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) CFO Jean Franchi sold 7,081 shares of the stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $65.47...
MarketBeat·10d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc...
PR Newswire·10d ago
News Placeholder
Insider Selling: Disc Medicine (NASDAQ:IRON) CFO Sells $256,154.50 in Stock
Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) CFO Jean Franchi sold 4,075 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $62.86, for a...
MarketBeat·10d ago
<
1
2
...
>

Latest IRON News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.